Skip to main content

4594 · BrightPath Biotherapeutics Co., Ltd. · Financials

39 JPY +0 (+0.00%) At close · Nov 12
Market Cap
5.42B JPY
Shares
138.89M
Volume · Nov 12 1.54M Avg daily vol (3M) 1.44M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
84K -92.6%
FY2026 Revenue FY2018–FY2026
Net Income
-1.3B -13.4%
FY2026 Net Income FY2018–FY2026
Gross Margin
64.29% -32.9pp
FY2026 Gross Margin FY2018–FY2026
Operating Margin
-1541667.86% -1439203.8pp
FY2026 Operating Margin FY2018–FY2026
Operating Cash Flow
-1.37B -9.2%
FY2026 Operating Cash Flow FY2018–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
JPY 84K 1.13M 72K 5.28M 15.41M 2.5M 11.3M 155.81M 354.41M
JPY 29K 32K 18K 1.9M 3.32M 1.15M 4.47M 70.7M 315.17M
JPY 54K 1.1M 54K 3.38M 12.09M 1.36M 6.83M 85.11M 39.24M
JPY -1.3B -1.16B -1.16B -1.47B -1.48B -1.73B -1.83B -1.67B -1.56B
JPY -1.3B -1.15B -1.17B -1.48B -1.48B -1.72B -1.86B -1.88B -1.57B
JPY 2.42M 1.9M 1.9M 1.9M 2.42M 2.42M -2.09M 3.79M 5.12M
JPY -1.3B -1.15B -1.17B -1.49B -1.48B -1.72B -1.86B -1.88B -1.58B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.